These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18776959)

  • 21. Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure.
    Wagoner LE; Craft LL; Zengel P; McGuire N; Rathz DA; Dorn GW; Liggett SB
    Am Heart J; 2002 Nov; 144(5):840-6. PubMed ID: 12422153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interactions between beta1 and beta2 adrenergic receptor polymorphisms as risk factors for chronic heart failure].
    Moraga F; Troncoso R; Mellado R; Díaz-Araya G; Vukasovic JL; Greig D; Perez O; García L; Roldán J; Ocaranza MP; Jali J; Chiong M; Castro P
    Rev Med Chil; 2008 Nov; 136(11):1371-80. PubMed ID: 19301767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphisms of adrenoceptors are not associated with an increased risk of adverse event in heart failure: a MERIT-HF substudy.
    Savva J; Maqbool A; White HL; Galloway SL; Yuldasheva NY; Ball SG; West RM; De Boer RA; Van Veldhuisen DJ; Balmforth AJ;
    J Card Fail; 2009 Jun; 15(5):435-41. PubMed ID: 19477404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure.
    Aleong RG; Sauer WH; Robertson AD; Liggett SB; Bristow MR
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):137-43. PubMed ID: 23275278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An aldosterone synthase gene variant is associated with improvement in left ventricular ejection fraction in dilated cardiomyopathy.
    Tiago AD; Badenhorst D; Skudicky D; Woodiwiss AJ; Candy GP; Brooksbank R; Sliwa K; Sareli P; Norton GR
    Cardiovasc Res; 2002 Jun; 54(3):584-9. PubMed ID: 12031704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study.
    Lee HY; Chung WJ; Jeon HK; Seo HS; Choi DJ; Jeon ES; Kim JJ; Shin JH; Kang SM; Lim SC; Baek SH
    Korean J Intern Med; 2016 Mar; 31(2):277-87. PubMed ID: 26879662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy.
    Forleo C; Resta N; Sorrentino S; Guida P; Manghisi A; De Luca V; Romito R; Iacoviello M; De Tommasi E; Troisi F; Rizzon B; Guanti G; Rizzon P; Pitzalis MV
    Am J Med; 2004 Oct; 117(7):451-8. PubMed ID: 15464701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy.
    Naya M; Tsukamoto T; Morita K; Katoh C; Nishijima K; Komatsu H; Yamada S; Kuge Y; Tamaki N; Tsutsui H
    J Nucl Med; 2009 Feb; 50(2):220-5. PubMed ID: 19164238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The natural history of acute dilated cardiomyopathy.
    Dec GW
    Trans Am Clin Climatol Assoc; 2014; 125():76-86; discussion 86-7. PubMed ID: 25125720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction.
    Ahmet I; Krawczyk M; Zhu W; Woo AY; Morrell C; Poosala S; Xiao RP; Lakatta EG; Talan MI
    J Pharmacol Exp Ther; 2008 May; 325(2):491-9. PubMed ID: 18287209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of therapeutic response to beta-blockers in patients with heart failure in Taiwan.
    Hu H; Jui HY; Hu FC; Chen YH; Lai LP; Lee CM
    J Formos Med Assoc; 2007 Aug; 106(8):641-8. PubMed ID: 17711797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms.
    O'Connor CM; Fiuzat M; Carson PE; Anand IS; Plehn JF; Gottlieb SS; Silver MA; Lindenfeld J; Miller AB; White M; Walsh R; Nelson P; Medway A; Davis G; Robertson AD; Port JD; Carr J; Murphy GA; Lazzeroni LC; Abraham WT; Liggett SB; Bristow MR
    PLoS One; 2012; 7(10):e44324. PubMed ID: 23071495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenergic receptor gene polymorphism and left ventricular reverse remodelling after cardiac resynchronization therapy: preliminary results.
    Pezzali N; Curnis A; Specchia C; Carubelli V; Covolo L; Donato F; Auricchio A; Regoli F; Metra M
    Europace; 2013 Oct; 15(10):1475-81. PubMed ID: 23729404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-Blocker Use Is Associated With Prevention of Left Ventricular Remodeling in Recovered Dilated Cardiomyopathy.
    Enzan N; Matsushima S; Ide T; Kaku H; Tohyama T; Funakoshi K; Higo T; Tsutsui H
    J Am Heart Assoc; 2021 Jun; 10(12):e019240. PubMed ID: 34053244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral endothelial function may predict the effectiveness of beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
    Xie X; Wu B; Chen Y; Li W; Hu X; Chen J
    Int J Cardiol; 2016 Oct; 221():128-33. PubMed ID: 27400309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy.
    Reddy S; Fung A; Manlhiot C; Tierney ES; Chung WK; Blume E; Kaufman BD; Goldmuntz E; Colan S; Mital S
    Pediatr Res; 2015 Feb; 77(2):363-9. PubMed ID: 25406899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Genetic Polymorphisms in the Beta-1 Adrenergic Receptor with Recovery of Left Ventricular Ejection Fraction in Patients with Heart Failure.
    Luzum JA; English JD; Ahmad US; Sun JW; Canan BD; Sadee W; Kitzmiller JP; Binkley PF
    J Cardiovasc Transl Res; 2019 Aug; 12(4):280-289. PubMed ID: 30756358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to catecholamine stimulation of polymorphisms of the beta-1 and beta-2 adrenergic receptors.
    McLean RC; Baird SW; Becker LC; Townsend SN; Gerstenblith G; Kass DA; Tomaselli GF; Schulman SP
    Am J Cardiol; 2012 Oct; 110(7):1001-7. PubMed ID: 22742717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of the uptake-1 norepinephrine transporter as measured by I-123 MIBG in heart failure patients with a loss-of-function polymorphism of the presynaptic alpha2C-adrenergic receptor.
    Gerson MC; Wagoner LE; McGuire N; Liggett SB
    J Nucl Cardiol; 2003; 10(6):583-9. PubMed ID: 14668769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.